Tanezumab In Osteoarthritis Of The Hip Or Knee
NCT00985621
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
614
Enrollment
INDUSTRY
Sponsor class
Stopped
See termination reason in detailed description.
Conditions
Osteoarthritis
Interventions
BIOLOGICAL:
tanezumab 10 mg
BIOLOGICAL:
tanezumab 5 mg
DRUG:
oxycodone
OTHER:
placebo
Sponsor
Pfizer